Database: Additional databases on drug expenditure (France): Difference between revisions

From Beacon
No edit summary
No edit summary
Line 6: Line 6:
'''Sponsor, manager or home institution:''' [[dataOwner::Caisse Nationale de l'Assurance Maladie (CNAM)]] [https://assurance-maladie.ameli.fr/].
'''Sponsor, manager or home institution:''' [[dataOwner::Caisse Nationale de l'Assurance Maladie (CNAM)]] [https://assurance-maladie.ameli.fr/].


'''Available type of information:''' [[availableVariable::atc code]], main anatomical group, therapeutic subgroup ([[availableVariable::drug group]]), pharmacological subgroup, chemical subgroup, pharmaceutical specialty identification code, generic group, [[availableVariable::age]] at the time of care, [[availableVariable::sex]], [[availableVariable::place of residence]], prescriber, [[availableVariable::costs reimbursement]], [[availableVariable::number of drugs]], [[availableVariable::number of patients]] (available only in NB_ type bases), [[availableVariable::year]].
'''Available type of information:''' [[hasDataDictionary::Open Medic: additional databases on drug expenditure]] [https://www.assurance-maladie.ameli.fr/etudes-et-donnees/open-medic-depenses-beneficiaires-medicaments].


'''Source of Information:''' Système National des Données de Santé (SNDS) [https://assurance-maladie.ameli.fr/etudes-et-donnees/presentation-systeme-national-donnees-sante-snds].
'''Source of Information:''' Système National des Données de Santé (SNDS) [https://assurance-maladie.ameli.fr/etudes-et-donnees/presentation-systeme-national-donnees-sante-snds].
Line 12: Line 12:
'''Available data level:''' [[availableDataLevel::regional level]].
'''Available data level:''' [[availableDataLevel::regional level]].


'''Number of Records:'''
'''Number of Records:''' [[numberRecords::unknown]].


'''Date Range:''' [[dataStart::2014]] [[dataEnd::onwards]].
'''Date Range:''' [[dataStart::2014]] [[dataEnd::onwards]].


'''Cancer Areas of Interest:'''
'''Cancer Areas of Interest:''' [[hasCancerType::C00-D48: All neoplasms]] [https://www.assurance-maladie.ameli.fr/etudes-et-donnees/open-medic-depenses-beneficiaires-medicaments].


'''Data access''': [[dataAvailability::publicly available]] [https://assurance-maladie.ameli.fr/etudes-et-donnees/open-medic-depenses-beneficiaires-medicaments].
'''Data access''': [[dataAvailability::publicly available]] [https://assurance-maladie.ameli.fr/etudes-et-donnees/open-medic-depenses-beneficiaires-medicaments].


'''Contact information:''' Information [https://assurance-maladie.ameli.fr/etudes-et-donnees/en-savoir-plus-snds/utilisation-accompagnement-donnees-snds].
'''Contact information:''' Information [https://assurance-maladie.ameli.fr/etudes-et-donnees/en-savoir-plus-snds/utilisation-accompagnement-donnees-snds].

Revision as of 19:09, 27 April 2024

Go back to France page

Primary purpose: Provides additional bases for medication expenses, enriched with beneficiary counts from all health insurance schemes in France. Offers insights into the number of people utilizing medications at various levels of grouping, along with indicators on amounts and box counts.

Sponsor, manager or home institution: Caisse Nationale de l'Assurance Maladie (CNAM) [1].

Available type of information: Open Medic: additional databases on drug expenditure [2].

Source of Information: Système National des Données de Santé (SNDS) [3].

Available data level: regional level.

Number of Records: unknown.

Date Range: 2014 onwards.

Cancer Areas of Interest: C00-D48: All neoplasms [4].

Data access: publicly available [5].

Contact information: Information [6].